January 20, 2017
The Food and Drug Administration approved the regimen of Opdivo and Yervoy as a treatment for metastatic melanoma in October 2015. 
January 20, 2017

The drug is indicated to treat adults with chronic idiopathic constipation.

January 19, 2017
The cream is indicated to treat persistent facial redness from rosacea in adults. 
January 19, 2017

Alongside the availability announcement, kaléo unveiled its Auvi-Q access program, AffordAbility, through which patients with commercial insurance will have an out-of-pocket cost of $0. 

January 18, 2017

The drug, indicated for pain severe enough to require daily, around-the-clock, long-term opioid treatment and patients for whom alternative therapy is inadequate, is formulated with Teva’s proprietary abuse-deterrent technology. 

January 18, 2017

The $960 million all-cash transaction is aimed at growing Lilly’s migraine pain management portfolio and will add a potential near-term launch to its late-stage pipeline. 

January 18, 2017

The study found that retrospective rebates, discounts and fees have increased from $67 billion in 2013 to $106 billion in 2015. 

January 17, 2017

Carsten Brun will oversee the company’s pharmaceutical arm in the United States, Canada, Central and Latin America, reporting to pharmaceutical division president and board of management member Dieter Weinand. 

 
January 12, 2017

The weekly Flu Index shows which populations are experiencing the most incidences of influenza each week based on Index methodology and does not measure actual levels or severity of flu activity, Walgreens noted.

January 11, 2017

Mayne Pharma acquired the products from GSK in August 2016, and they complement the company’s Doryx, the first branded product in its specialty brands division that it launched in 2015. 

January 10, 2017

The drug is indicated for long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis or emphysema. 

January 10, 2017

Egalet said Arymo ER is the first drug approved using its proprietary Guardian Technology, which works to deter abuse and prevent the tablets from being manipulated for abuse or misuse. 

January 9, 2017

Johnson and Johnson worldwide chairman, pharmaceuticals, Joaquin  Duato will be the next board chairman of PhRMA. 

January 6, 2017

The number of drugs the FDA approved last year, 22, is less than half of the 45 approved in 2015 and lower than the average of the last 10 years of approvals, which is 29. 

January 6, 2017
This is the fifth approved indication for Lucentis. 
January 6, 2017

U.S. District Court Judge Sue Robinson on Thursday issued an injunction on the sale of Praluent, a PCSK9 inhibitor from Sanofi and Regeneron. Amgen, maker of another PCSK9 inhibitor Repatha, filed the request for the injunction in 2016.

January 5, 2017

FHC's new chief commercial officer will be responsible for all sales and marketing activities, with the goal of coordinating prelaunch, launch and sales and marketing activities.

January 4, 2017

Dr. Jay Markowitz will work with other scientific and development leaders to evaluate the company’s portfolio evaluation and decision making while assessing external opportunities. 

January 4, 2017

The drug, approved by the Food and Drug Administration in November, is indicated to treat adults with Type 2 diabetes that’s inadequately controlled on basal insulin or lixisenatide. 

January 3, 2017
Forbes is reporting that the Food and Drug Administration’s approval of 22 new drugs in 2016 (down from 51 in 2015) could have big implications for the future of innovation in the pharmaceutical space. The report notes that research spending is growing, but there are practical difficulties to translate innovation into products as R&D returns decline  — and the report suggests overcoming that difficulty could mean rethinking a lot. (Forbes)
 
December 27, 2016

Spinraza treats SMA, a rare and often fatal genetic disease affecting muscle strength and movement.

December 27, 2016

Novo Nordisk accused of issuing marketing materials asking patients and doctors to switch from Sanofi’s Lantus and Toujeo drugs to Tresiba, because the Sanofi drugs will be “blocked” by CVS Caremark in January.

December 22, 2016

Dexcom’s G5 Mobile allows for testing for diabetes treatment decisions in people 2 years of age and older with diabetes.

December 21, 2016

Systemic inflammatory conditions combined affect more than 2 million Americans.